Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome

Clinical Classification of Age-related Macular Degeneration

Frederick L. Ferris, Charles P. Wilkinson, Alan C. Bird et al. · Ophthalmology · 2013 · 1.7K citations · Full text

Age-related Diseases, Ocular Disease, Ophthalmology +1

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.5K citations · Full text

Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

T Sacks, Charles F. Moldow, P R Craddock et al. · Journal of Clinical Investigation · 1978 · 1.1K citations · Full text

Immunology, Blood Cell, Cell Death +21

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H

Matthew C. Pickering, H. Terence Cook, Joanna Warren et al. · Nature Genetics · 2002 · 500 citations

Glomerular Disease, Glomerulonephritis, Inflammation +14

Complement Factor H Polymorphism, Complement Activators, and Risk of Age-Related Macular Degeneration

Dominiek D. G. Despriet, Caroline C. W. Klaver, Jacqueline C.M. Witteman et al. · JAMA · 2006 · 346 citations · Full text